ATE84713T1 - Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome. - Google Patents

Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.

Info

Publication number
ATE84713T1
ATE84713T1 AT86106111T AT86106111T ATE84713T1 AT E84713 T1 ATE84713 T1 AT E84713T1 AT 86106111 T AT86106111 T AT 86106111T AT 86106111 T AT86106111 T AT 86106111T AT E84713 T1 ATE84713 T1 AT E84713T1
Authority
AT
Austria
Prior art keywords
withdrawal symptoms
calcium antagonists
preparing compositions
compositions
opioid
Prior art date
Application number
AT86106111T
Other languages
English (en)
Inventor
Esam E El-Fakahany
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ATE84713T1 publication Critical patent/ATE84713T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
AT86106111T 1985-05-13 1986-05-05 Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome. ATE84713T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73366485A 1985-05-13 1985-05-13
EP86106111A EP0204951B1 (de) 1985-05-13 1986-05-05 Verwendung von Kalziumantagonisten zur Anfertigung von Zusammensetzungen für Entziehungssymptome

Publications (1)

Publication Number Publication Date
ATE84713T1 true ATE84713T1 (de) 1993-02-15

Family

ID=24948609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86106111T ATE84713T1 (de) 1985-05-13 1986-05-05 Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.

Country Status (6)

Country Link
US (1) US4797410A (de)
EP (1) EP0204951B1 (de)
JP (1) JPS61260025A (de)
AT (1) ATE84713T1 (de)
CA (1) CA1275928C (de)
DE (1) DE3687541T2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806277A1 (de) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg Verwendung von 1,4-dihydropyridin-derivaten
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
HUT70033A (en) * 1989-03-22 1995-09-28 Pang Process for producing synergetic pharmaceutical composition containing calcium channel blocking agent and calcium compound or vitamin d
CA2016465A1 (en) * 1989-06-02 1990-12-02 Zola Phillip Horovitz Method for preventing or treating anxiety employing a calcium channel blocker
US5124340A (en) * 1989-06-28 1992-06-23 The United States Of America As Represented By The Department Of Health And Human Services Use of calcium channel blocker to prevent cocaine induced craving and reinforcement
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
ES2200158T3 (es) * 1996-03-08 2004-03-01 Nycomed Danmark Aps Cmpuesto de dosificacion de unidades multiples, de liberacion modificada.
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
GB0019055D0 (en) * 2000-08-03 2000-09-27 Unilever Plc Antiperspirant and deodorant products and methods for their use
IL155637A0 (en) 2000-10-30 2003-11-23 Euro Celtique Sa Controlled release hydrocodone formulations
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
EP2068840A2 (de) * 2006-07-21 2009-06-17 LAB International SRL Hydrophobes missbrauchssicheres ausgabesystem
US20170071879A1 (en) * 2015-09-15 2017-03-16 Alexandre Vamvakides Prototypical analgesic profile of 3,3-diphenyl-n-(1-phenylethyl)propan-1-amine (fendiline)
GR1009145B (el) * 2016-08-10 2017-10-20 Αλεξανδρος Δημητριου Βαμβακιδης Πρωτοτυπη αναλγητικη δραση της 3,3-διφαινυλο-ν-(1-φαινυλαιθυλ) προπαν-1-αμινη (fendiline)

Also Published As

Publication number Publication date
US4797410A (en) 1989-01-10
DE3687541D1 (de) 1993-03-04
EP0204951B1 (de) 1993-01-20
EP0204951A2 (de) 1986-12-17
DE3687541T2 (de) 1993-05-13
JPS61260025A (ja) 1986-11-18
CA1275928C (en) 1990-11-06
EP0204951A3 (en) 1990-05-30
JPH0584287B2 (de) 1993-12-01

Similar Documents

Publication Publication Date Title
ATE84713T1 (de) Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.
ZA877385B (en) Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
ATA204086A (de) Geraet zur verabreichung von medikamenten in pulverform
DE3575428D1 (de) Kristallinisches kalzium-pseudomonat und verwendung.
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
PH25430A (en) Pharmaceutical compositions containing calcium salts
DK49488A (da) Anaestesi-praeparat
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
GB2181354B (en) Improvements relating to orthopaedic implants
IL92180A (en) Pharmaceutical composition for preventing or reducing eosinophilia
EP0204129A3 (de) Verwendung von Kalziumantagonisten zur Anfertigung von Zusammensetzungen für die rekonstruktive Chirurgie
DE3781618D1 (de) Praeparat zur oralen verwendung.
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
AT379624B (de) Vorrichtung zur sicherung der lage der zungenschienen von gleisweichen
DK623984D0 (da) Farmaceutisk doseringsenhed
DK453785D0 (da) Laegemiddel med grf-virkning
ATE86481T1 (de) Dosisform zur verabreichung von calciumantagonisten.
DE3575261D1 (de) Implantables befestigungsmittel fuer zahnprothesen.
DE68905343D1 (de) Dosisform zur verabreichung von calciumantagonisten.
BR6802788U (pt) Circuito de via de estrada de ferro para detectar presenca de um trem
IT8454104V0 (it) Gioco anagrafico per tutti
BR6700850U (pt) Regua para medicao de bitolas
IT8648751A0 (it) 1-n-propil-3-(2-metil-butil)-7-(5idrossiesil)-8-alchil-xantine ad attivita' antibroncospastica,composizioni farmaceutiche che le contengono e relativo procedimento per laloro preparazione
PHUM6208Z (en) Improved railroad spike
MX162631A (es) Procedimiento para el tratamiento de durmientes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee